Follow
Keith Lumbard
Keith Lumbard
Leidos Biomedical Research, Inc.
Verified email at nih.gov
Title
Cited by
Cited by
Year
A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV …
LK Dropulic, MC Oestreich, HL Pietz, KJ Laing, S Hunsberger, K Lumbard, ...
The Journal of infectious diseases 220 (6), 990-1000, 2019
502019
A randomized double-blind, placebo-controlled study of omalizumab for idiopathic anaphylaxis
MC Carter, I Maric, EH Brittain, Y Bai, K Lumbard, H Bolan, D Cantave, ...
Journal of Allergy and Clinical Immunology, 2020
292020
Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model
A Han, L Czajkowski, LA Rosas, A Cervantes-Medina, Y Xiao, ...
Clinical Infectious Diseases, 2020
272020
Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis
YL Xie, VR de Jager, RY Chen, LE Dodd, P Paripati, LE Via, D Follmann, ...
Science Translational Medicine 13 (579), 2021
262021
Prevalence and diagnosis of sesame allergy in children with IgE-mediated food allergy
K Sokol, M Rasooly, C Dempsey, S Lassiter, W Gu, K Lumbard, ...
Pediatric allergy and immunology: official publication of the European …, 2020
222020
Single-Organ and Multisystem Hypereosinophilic Syndrome Patients with Gastrointestinal Manifestations Share Common Characteristics
FL Kuang, BF Curtin, H Alao, B Piligian, A Berry, N Holland-Thomas, ...
The Journal of Allergy and Clinical Immunology: In Practice 8 (8), 2718-2726. e2, 2020
182020
Confidence intervals for difference in proportions for matched pairs compatible with exact McNemar's or sign tests
MP Fay, K Lumbard
Statistics in Medicine 40 (5), 1147-1159, 2021
162021
Post-treatment Lyme disease symptoms score: Developing a new tool for research
SP Turk, K Lumbard, K Liepshutz, C Williams, L Hu, K Dardick, ...
PloS one 14 (11), e0225012, 2019
162019
Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation area
A Gouel-Cheron, K Lumbard, S Hunsberger, FJ Arteaga-Cabello, J Beigel, ...
Antiviral research 172, 104638, 2019
112019
Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective …
S Hunsberger, AM Ortega-Villa, JH Powers III, HAR León, SC Sosa, ...
International Journal of Infectious Diseases 98, 241-248, 2020
102020
Using multiple data streams to estimate and forecast SARS-CoV-2 transmission dynamics, with application to the virus spread in Orange County, California.
J Fintzi, D Bayer, I Goldstein, K Lumbard, E Ricotta, S Warner, LM Busch, ...
Arxiv, arXiv: 2009.02654 v1-arXiv: 2009.02654 v1, 2020
82020
Exact 2x2: exact tests and confidence intervals for 2x2 tables
MP Fay, SA Hunsberger, M Nason, E Gabriel, K Lumbard
R package version 1 (6), 2021
72021
A Phase I, Randomized, Controlled Clinical Study of CC-11050 in People Living With HIV With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)
A Boulougoura, E Gabriel, E Laidlaw, V Khetani, K Arakawa, J Higgins, ...
Open forum infectious diseases 6 (6), ofz246, 2019
52019
Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine
K Wang, L Dropulic, J Bozekowski, HL Pietz, S Jegaskanda, K Dowdell, ...
The Journal of Infectious Diseases, 2021
32021
Noninferiority testing with censoring when the event rate is low
SK Gallagher, J Wang, K Lumbard, LE Dodd, M Proschan
Statistics in Medicine 41 (25), 5102-5112, 2022
12022
Exact Tests and Confidence Intervals for 2x2 Tables
MP Fay, SA Hunsberger, M Nason, E Gabriel, K Lumbard
12020
Half blind superiority tests for clinical trials of anti‐infective drugs
D Follmann, E Brittain, K Lumbard
Statistics in medicine 38 (1), 31-43, 2019
12019
Package ‘exact2x2’
MP Fay, SA Hunsberger, M Nason, E Gabriel, K Lumbard, MMP Fay
2024
Semi-parametric modeling of SARS-CoV-2 transmission using tests, cases, deaths, and seroprevalence data
D Bayer, IH Goldstein, J Fintzi, K Lumbard, E Ricotta, S Warner, LM Busch, ...
ArXiv, 2023
2023
exact2x2-package: Exact Tests and Confidence Intervals for 2x2 Tables
MP Fay, SA Hunsberger, M Nason, E Gabriel, K Lumbard
2020
The system can't perform the operation now. Try again later.
Articles 1–20